Sage Rhino Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $856K | Sell |
12,251
-8
| -0.1% | -$559 | 0.18% | 97 |
|
|
2025
Q1 | $901K | Buy |
12,259
+395
| +3% | +$29K | 0.21% | 91 |
|
|
2024
Q4 | $777K | Sell |
11,864
-160
| -1% | -$10.5K | 0.17% | 102 |
|
|
2024
Q3 | $937K | Buy |
12,024
+149
| +1% | +$11.6K | 0.21% | 94 |
|
|
2024
Q2 | $926K | Buy |
11,875
+247
| +2% | +$19.3K | 0.22% | 90 |
|
|
2024
Q1 | $788K | Buy |
11,628
+246
| +2% | +$16.7K | 0.19% | 102 |
|
|
2023
Q4 | $767K | Sell |
11,382
-134
| -1% | -$9.03K | 0.2% | 98 |
|
|
2023
Q3 | $780K | Buy |
11,516
+155
| +1% | +$10.5K | 0.22% | 89 |
|
|
2023
Q2 | $813K | Buy |
11,361
+588
| +5% | +$42.1K | 0.23% | 91 |
|
|
2023
Q1 | $748K | Buy |
10,773
+150
| +1% | +$10.4K | 0.22% | 89 |
|
|
2022
Q4 | $720K | Sell |
10,623
-366
| -3% | -$24.8K | 0.23% | 89 |
|
|
2022
Q3 | $603K | Sell |
10,989
-333
| -3% | -$18.3K | 0.24% | 77 |
|
|
2022
Q2 | $748K | Buy |
11,322
+415
| +4% | +$27.4K | 0.29% | 59 |
|
|
2022
Q1 | $724K | Buy |
10,907
+503
| +5% | +$33.4K | 0.22% | 83 |
|
|
2021
Q4 | $606K | Buy |
10,404
+1,326
| +15% | +$77.2K | 0.17% | 107 |
|
|
2021
Q3 | $545K | Buy |
9,078
+857
| +10% | +$51.5K | 0.17% | 99 |
|
|
2021
Q2 | $492K | Buy |
8,221
+436
| +6% | +$26.1K | 0.15% | 109 |
|
|
2021
Q1 | $387K | Buy |
7,785
+147
| +2% | +$7.31K | 0.13% | 116 |
|
|
2020
Q4 | $382K | Sell |
7,638
-2,403
| -24% | -$120K | 0.15% | 109 |
|
|
2020
Q3 | $550K | Buy |
10,041
+190
| +2% | +$10.4K | 0.27% | 76 |
|
|
2020
Q2 | $521K | Buy |
9,851
+207
| +2% | +$10.9K | 0.28% | 79 |
|
|
2020
Q1 | $431K | Buy |
9,644
+4,208
| +77% | +$188K | 0.31% | 71 |
|
|
2019
Q4 | $271K | Buy |
5,436
+102
| +2% | +$5.09K | 0.15% | 116 |
|
|
2019
Q3 | $238K | Buy |
5,334
+132
| +3% | +$5.89K | 0.15% | 119 |
|
|
2019
Q2 | $215K | Buy |
+5,202
| New | +$215K | 0.14% | 121 |
|